NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/15/2025
Back to search
Official data from USPTO
8
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
04/16/2025
Trademark type
Combined
Nice classes
1
Filing date
01/10/2024
Registration date
04/15/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/15/2025
Last transaction
04/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/16/2021
First use in commerce
05/07/2023
Drawing code
3
Owner type
99
Owner location
Guangzhou, Guangdong, CN
Examiner
MORAN, CAROLINE
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a horizontal figure 8 with a pointed design protruding from the upper left corner, and four interwoven short lines inside an oval in the right.
Holders and representatives
Holders
ARGORNA PHARMACEUTICALS CO., LTD
Representatives
Jonathan M. Rixen Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active pharmaceutical ingredients (APIs)oligonucleotide APIs for use in the manufacture of pharmaceuticals for treating tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; active chemical ingredients for use in the manufacture of pharmaceuticals for treating tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/15/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/24/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/24/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/21/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/21/2025
IUAF
USE AMENDMENT FILED
01/16/2025
EISU
TEAS STATEMENT OF USE RECEIVED
01/16/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/14/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/14/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
01/14/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/14/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/14/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/13/2024
PUBO
PUBLISHED FOR OPPOSITION
08/13/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/09/2024
DOCK
ASSIGNED TO EXAMINER
06/17/2024
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/01/2024
NWAP
NEW APPLICATION ENTERED
01/10/2024
Continuous trademark protection
Get notified about every new filing that threatens 8 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.